vs
合众银行（FSBC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是合众银行的1.7倍（$75.5M vs $45.1M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 21.3%）
合众银行是总部设在美国明尼阿波利斯、在特拉华州注册的美国跨国银行机构，截至2025年为美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的银行。它旗下核心运营实体为美国银行全国协会，以US Bank品牌开展业务，提供银行、投资、抵押等金融服务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
FSBC vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.7倍
$45.1M
两年增速更快
PBYI
近两年复合增速
21.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $75.5M |
| 净利润 | $18.6M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 41.3% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | 42.0% | — |
| 每股收益（稀释后） | $0.87 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FSBCPBYI
| Q1 26 | $45.1M | — | ||
| Q4 25 | $43.5M | $75.5M | ||
| Q3 25 | $41.3M | $54.5M | ||
| Q2 25 | $38.3M | $52.4M | ||
| Q1 25 | $35.3M | $46.0M | ||
| Q4 24 | $35.2M | $59.1M | ||
| Q3 24 | $31.8M | $80.5M | ||
| Q2 24 | $30.7M | $47.1M |
净利润FSBCPBYI
| Q1 26 | $18.6M | — | ||
| Q4 25 | $17.6M | — | ||
| Q3 25 | $16.3M | $8.8M | ||
| Q2 25 | $14.5M | $5.9M | ||
| Q1 25 | $13.1M | $3.0M | ||
| Q4 24 | $13.3M | — | ||
| Q3 24 | $10.9M | $20.3M | ||
| Q2 24 | $10.8M | $-4.5M |
毛利率FSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率FSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | 22.7% | ||
| Q3 25 | 53.8% | 17.6% | ||
| Q2 25 | 52.4% | 12.7% | ||
| Q1 25 | 52.0% | 8.7% | ||
| Q4 24 | 55.1% | 22.6% | ||
| Q3 24 | 48.0% | 27.4% | ||
| Q2 24 | 49.4% | -4.6% |
净利率FSBCPBYI
| Q1 26 | 41.3% | — | ||
| Q4 25 | 40.6% | — | ||
| Q3 25 | 39.6% | 16.2% | ||
| Q2 25 | 37.9% | 11.2% | ||
| Q1 25 | 37.1% | 6.5% | ||
| Q4 24 | 37.9% | — | ||
| Q3 24 | 34.4% | 25.2% | ||
| Q2 24 | 35.2% | -9.6% |
每股收益（稀释后）FSBCPBYI
| Q1 26 | $0.87 | — | ||
| Q4 25 | $0.83 | $0.26 | ||
| Q3 25 | $0.77 | $0.17 | ||
| Q2 25 | $0.68 | $0.12 | ||
| Q1 25 | $0.62 | $0.06 | ||
| Q4 24 | $0.61 | $0.40 | ||
| Q3 24 | $0.52 | $0.41 | ||
| Q2 24 | $0.51 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $644.4M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $458.5M | $130.3M |
| 总资产 | $5.0B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资FSBCPBYI
| Q1 26 | $644.4M | — | ||
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M |
总债务FSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益FSBCPBYI
| Q1 26 | $458.5M | — | ||
| Q4 25 | $445.8M | $130.3M | ||
| Q3 25 | $431.3M | $115.3M | ||
| Q2 25 | $416.7M | $104.7M | ||
| Q1 25 | $406.5M | $97.1M | ||
| Q4 24 | $396.6M | $92.1M | ||
| Q3 24 | $389.9M | $71.1M | ||
| Q2 24 | $380.5M | $48.5M |
总资产FSBCPBYI
| Q1 26 | $5.0B | — | ||
| Q4 25 | $4.8B | $216.3M | ||
| Q3 25 | $4.6B | $202.9M | ||
| Q2 25 | $4.4B | $194.9M | ||
| Q1 25 | $4.2B | $196.2M | ||
| Q4 24 | $4.1B | $213.3M | ||
| Q3 24 | $3.9B | $220.7M | ||
| Q2 24 | $3.6B | $205.0M |
负债/权益比FSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流FSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | $72.6M | $14.4M | ||
| Q3 25 | $18.8M | $9.7M | ||
| Q2 25 | $17.8M | $14.1M | ||
| Q1 25 | $15.5M | $3.6M | ||
| Q4 24 | $51.8M | $15.6M | ||
| Q3 24 | $17.5M | $11.0M | ||
| Q2 24 | $16.0M | $1.0M |
自由现金流FSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | $71.4M | $14.4M | ||
| Q3 25 | $18.6M | $9.7M | ||
| Q2 25 | $17.5M | $14.1M | ||
| Q1 25 | $15.4M | $3.6M | ||
| Q4 24 | $51.2M | $15.6M | ||
| Q3 24 | $17.3M | $11.0M | ||
| Q2 24 | $15.8M | $1.0M |
自由现金流率FSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | 164.3% | 19.1% | ||
| Q3 25 | 45.0% | 17.7% | ||
| Q2 25 | 45.8% | 26.8% | ||
| Q1 25 | 43.5% | 7.7% | ||
| Q4 24 | 145.5% | 26.4% | ||
| Q3 24 | 54.5% | 13.7% | ||
| Q2 24 | 51.6% | 2.1% |
资本支出强度FSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | 2.8% | 0.0% | ||
| Q3 25 | 0.5% | 0.0% | ||
| Q2 25 | 0.6% | 0.0% | ||
| Q1 25 | 0.3% | 0.1% | ||
| Q4 24 | 1.8% | 0.0% | ||
| Q3 24 | 0.7% | 0.0% | ||
| Q2 24 | 0.7% | 0.0% |
现金转化率FSBCPBYI
| Q1 26 | — | — | ||
| Q4 25 | 4.12× | — | ||
| Q3 25 | 1.15× | 1.10× | ||
| Q2 25 | 1.23× | 2.41× | ||
| Q1 25 | 1.18× | 1.21× | ||
| Q4 24 | 3.89× | — | ||
| Q3 24 | 1.60× | 0.54× | ||
| Q2 24 | 1.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FSBC
| Net Interest Income | $43.5M | 96% |
| Noninterest Income | $1.6M | 4% |
PBYI
暂无分部数据
